Mikako Ito
Nihon University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mikako Ito.
Journal of Clinical Microbiology | 2004
Mikako Ito; Tomohiko Takasaki; Ken-Ichiro Yamada; Reiko Nerome; Shigeru Tajima; Ichiro Kurane
ABSTRACT The fluorogenic TaqMan reverse transcriptase PCR (RT-PCR) assay was developed for detecting each of the dengue virus (DV) types 1 to 4. DV genome was detected in all the 35 serum samples from confirmed dengue cases by the TaqMan RT-PCR, although it was not detected in 13 and 21% by conventional type-specific and cross-reactive RT-PCR, respectively.
Journal of Clinical Virology | 2003
Mikako Ito; Takuya Itou; Youko Shoji; Takeo Sakai; Fumio Honma Ito; Yohko T. Arai; Tomohiko Takasaki; Ichiro Kurane
BACKGROUND There is a geographical overlap between the two main rabies epidemiological cycles maintained by dogs and vampire bats in Latin America. The geographical and temporal coincidence of rabies outbreaks of respective origins is not unusual in rural areas of Latin America. These circumstances make it difficult to discriminate the intraspecies and interspecies transmission pathways of rabies. OBJECTIVE This study was conducted to develop techniques to discriminate dog-related and vampire bat-related rabies virus isolates (DRRV and VRRV, respectively) in Brazil. STUDY DESIGN The 1396 nucleotides of the nucleoprotein gene of a total of 27 DRRV and VRRV were sequenced. Strain-specific (SS) primers were developed based on these sequences. Forty-nine rabies virus strains isolated from animals and humans in several parts of Brazil were examined by reverse transcriptase-polymerase chain reaction (RT-PCR) with SS primers. These rabies viruses were also amplified by RT-PCR with general rabies primers and the PCR products were cut by three restriction enzymes, Blp I, Bsu36 I and BspE I. RESULTS All the DRRV and VRRV were distinguished by RT-PCR with SS primers. The PCR products obtained from DRRV were cut at one site by Blp I, but not by Bsu36 I. The PCR products obtained from VRRV were cut at one or two sites by Bsu36 I, but not by Blp I. Blp I and Bsu36 I clearly discriminated DRRV and VRRV in restriction fragment length polymorphysim (RFLP) assays. The results of SS RT-PCR and RFLP were consistent. CONCLUSION SS RT-PCR and RFLP assays have been developed for determining the origins of rabies virus isolates in Brazil. These assays are simple and rapid, and will be useful for identifying the rabies virus reservoirs of field isolates in Brazil, especially when used together.
Emerging Infectious Diseases | 2005
Masaru Kuwayama; Mikako Ito; Shinichi Takao; Yukie Shimazu; Shinji Fukuda; Kazuo Miyazaki; Ichiro Kurane; Tomohiko Takasaki
Cerebrospinal fluid specimens from 57 patients diagnosed with meningitis were tested for Japanese encephalitis virus. Total RNA was extracted from the specimens and amplified. Two products had highest homology with Nakayama strain and 2 with Ishikawa strain. Results suggest that Japanese encephalitis virus causes some aseptic meningitis in Japan.
Emerging Infectious Diseases | 2007
Tetsuya Mizutani; Daiji Endoh; Michiko Okamoto; Kazuya Shirato; Hiroyuki Shimizu; Minetaro Arita; Shuetsu Fukushi; Masayuki Saijo; Chang Kweng Lim; Mikako Ito; Reiko Nerome; Tomohiko Takasaki; Koji Ishii; Tetsuro Suzuki; Ichiro Kurane; Shigeru Morikawa; Hidekazu Nishimura
We developed a system for rapid determination of viral RNA sequences whereby genomic sequence is obtained from cultured virus isolates without subcloning into plasmid vectors. This method affords new opportunities to address the challenges of unknown or untypeable emerging viruses.
American Journal of Tropical Medicine and Hygiene | 2009
Chang-Kweng Lim; Takeaki Nishibori; Kanako Watanabe; Mikako Ito; Akira Kotaki; Keiko Tanaka; Ichiro Kurane; Tomohiko Takasaki
A large-scale epidemic of chikungunya (CHIK) fever occurred in several Indian Ocean islands in 2004 and spread to India and Sri Lanka. In December 2006, a returnee to Japan from Sri Lanka developed an acute febrile illness. The patient was confirmed to have CHIK fever after reverse transcription-polymerase chain reaction, and specific IgM and IgG detection. CHIK virus was isolated from the serum specimen collected at the acute stage. The isolated virus developed two different sizes of plaques. Two sub-strains with different genetic and biological characteristics were obtained by plaque purification from one isolate. The entire genome was sequenced and phylogenetic analysis of the E1 genome showed that the sub-strains were of the Central/East African genotype, and were closely related to recent isolates in India. This is the first report of CHIK virus genome sequences isolated from a patient infected in Sri Lanka.
Archives of Virology | 2010
Mikako Ito; Ryo-zabro Mukai; Tomohiko Takasaki; Akira Kotaki; Ichiro Kurane
Two monkeys (Macaca fascicularis) each were infected with dengue virus type 1 (DENV-1) and type 2 (DENV-2). High levels of neutralizing antibody to homotypic serotype were detected from day 10 to week 58 after infection. Levels of cross-reactive neutralizing antibody to other serotypes were at lower levels or undetectable. Serum samples collected from day 10 to week 58 enhanced infection by homotypic and heterotypic serotypes of DENV when diluted, demonstrating antibody-dependent enhancement (ADE). The ADE activities to heterotypic and homotypic dengue virus infections peaked at dilutions of 1:10–1:100 and 1:100–1:1,000, respectively. Serum samples collected enhanced heterotypic dengue virus infection without any dilution. The results indicate that sera from infected monkeys have an ability to enhance heterotypic dengue virus infection in vitro without dilution, although some of these sera also possess neutralizing activity.
Archives of Virology | 2011
Mikako Ito; Yuko Katakai; Fumiko Ono; Hirofumi Akari; Ryo-zabro Mukai; Tomohiko Takasaki; Akira Kotaki; Ichiro Kurane
Neutralizing antibody responses were examined in monkeys after dengue virus infections. In monkeys that had been infected once or twice with DENV-2, neutralizing antibody was cross-reactive with all four serotypes after secondary or tertiary infection with DENV-3. In monkeys that had been inoculated with DENV-1 and DENV-2 in the primary and secondary infections, neutralizing antibody titers did not increase after tertiary infection with DENV-3. These results indicate that antibody responses after secondary and tertiary infections with different serotypes are cross-reactive with all four serotypes, consistent with what has been observed in humans, and suggest that monkeys are useful for determining neutralizing antibody responses.
Virology | 2001
Mikako Ito; Yohko T. Arai; Takuya Itou; Takeo Sakai; Fumio Honma Ito; Tomohiko Takasaki; Ichiro Kurane
Journal of Veterinary Medical Science | 2004
Go Sato; Takuya Itou; Youko Shoji; Yasuo Miura; Takeshi Mikami; Mikako Ito; Ichiro Kurane; Samir Issa Samara; A. A. B. Carvalho; Darci Lara Perecin Nociti; Fumio Honma Ito; Takeo Sakai
Journal of Travel Medicine | 2007
Mikako Ito; Ken-Ichiro Yamada; Tomohiko Takasaki; Basu Dev Pandey; Reiko Nerome; Shigeru Tajima; Kouichi Morita; Ichiro Kurane